Coloplast A/S
Coloplast A/S (CLPBY) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
clpby · stock forecast · 8 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Buy
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$14.45
Consensus
$14.45
+143.3% upside
Low
$14.45
Median: $14.45 · Last Close: $5.94
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $5.77 | ↓ 2.87% |
1-day model range: $5.75–$5.79. Peak: $5.79 (-2.87%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -20.4% |
| 2028 | $4 | -30.9% |
| 2029 | $4 | -36.8% |
| 2030 | $4 | -40.4% |
| 2031 | — | -42.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CLPBY · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|
Wall Street analysts have recently issued updated ratings on Coloplast A/S (CLPBY) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 8 analysts currently cover CLPBY.
Analyst Recommendation Trends
CLPBY analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$29.2B
↓ 12.3% YoY
Revenue Next Year
$31.2B
↑ 6.9% YoY
EPS This Year
$2.54
EPS Next Year
$2.71
↑ 7.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast CLPBY EPS of $2.54 for the current fiscal year, based on estimates from 2 analysts. The CLPBY revenue forecast is $29.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CLPBY stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CLPBY price target is $14.45 (+143.3% upside), with an analyst consensus of Buy.
The CLPBY short-term stock prediction for tomorrow is $5.77 (-2.87%). The CLPBY stock price prediction for 2027 estimates an average of $5. The CLPBY stock prediction for 2030 projects a range of $3–$4.
Coloplast A/S trades on OTC under the ticker CLPBY. The CLPBY stock outlook for 2027 is broadly positive, supported by a Buy consensus among 38% of covering analysts.
Frequently asked questions
CLPBY forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month CLPBY price target is $14.45, with a high forecast of $14.45 and a low of $14.45. The median price target is shown in the chart above when available. This implies +143.3% potential upside from the current price of $5.94.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.